Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Tan
Reducing TNF Receptor 2 + Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
Clinical Cancer Research
Cancer Research
Oncology
The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study
Oncotarget
Oncology
Related publications
Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α–TNF Receptor-2 Pathway
Frontiers in Immunology
Allergy
Immunology
Indoleamine 2,3-Dioxygenase and Regulatory T Cells in Acute Myeloid Leukemia
Hematology
Hematology
Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
Frontiers in Immunology
Allergy
Immunology
A Regimen Combining the Wee1 Inhibitor AZD1775 With HDAC Inhibitors Targets Human Acute Myeloid Leukemia Cells Harboring Various Genetic Mutations
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Frontiers in Oncology
Cancer Research
Oncology
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
PLoS ONE
Multidisciplinary
Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-Cd33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia
PLoS ONE
Multidisciplinary
Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies
American Journal of Hematology
Hematology
